MARC

LEADER 00000cam a2200000Mu 4500
001 EBOOKCENTRAL_ocn963568305
003 OCoLC
005 20240329122006.0
006 m o d
007 cr |n|---|||||
008 161119s2016 enk ob 000 0 eng d
040 |a EBLCP  |b eng  |e pn  |c EBLCP  |d OCLCQ  |d IDB  |d OCLCO  |d CUY  |d OCLCF  |d OCLCQ  |d ZCU  |d MERUC  |d ICG  |d VT2  |d DKC  |d OCLCQ  |d UKAHL  |d OCLCQ  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCL 
020 |a 9781780408316 
020 |a 1780408315 
035 |a (OCoLC)963568305 
050 4 |a QR201.E16  |b .R575 2016eb 
082 0 4 |a 614.57  |2 23 
049 |a UAMI 
100 1 |a Bibby, Kyle. 
245 1 0 |a Risks from Ebola Discharge from Hospitals to Sewer Workers. 
260 |a London :  |b IWA Publishing,  |c 2016. 
300 |a 1 online resource (64 pages) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a WERF Research Report Series ;  |v v. WERF4C15 
588 0 |a Print version record. 
505 0 |a Cover; Copyright; Acknowledgments; Abstract and Benefits; Table of Contents; List of Tables; List of Figures; List of Abbreviations and Acronyms; Executive Summary; Chapter 1.0: Study Significance; Chapter 2.0: Quantitative Microbial Risk Assessment; 2.1 Introduction; 2.2 Materials and Methods; 2.2.1 Exposure Assessment; 2.2.2 Dose-Response Assessment; 2.2.3 Risk Characterization; 2.3 Results and Discussion; 2.3.1 Exposure Assessment; 2.3.1.1 Patient Excreta and Secreta Production to Sewer; 2.3.1.2 Excreta and Secreta Concentrations of EBOV. 
505 8 |a 2.3.1.3 Hospital Daily Outflow (For internal dilution rate in hospital)2.3.1.4 Interceptor Daily Flow (For dilution from hospital discharge to sewer to point of worker exposure); 2.3.1.5 EBOV Die-Off Rate; 2.3.1.6 Sewer Travel Time from Patient to Point of Worker Exposure; 2.3.1.7 Partition Coefficient (Ratio of aerosol concentration of EBOV to liquid concentration); 2.3.1.8 Respirable Fraction (Fraction of aerosols generated that are respirable); 2.3.1.9 Worker Inhalation Rate; 2.3.1.10 EBOV Removal Fraction by Worker PPE; 2.3.1.11 Time Spent by a Sewer Worker in the Proximity. 
505 8 |a 2.3.1.12 Conversion from EBOV RNA Copies to PFUs2.3.1.13 Dose of Respirable EBOV Inhaled and Retained in Lungs per Exposure; 2.3.2 Dose-Response Assessment; 2.3.3 Risk Characterization; 2.4 Conclusions; Chapter 3.0: Inactivation Review; 3.1 Background and Results; Appendix A: Ebola Risks/Discharge Frequently Asked Questions; Appendix B: Inactivation Matrix; Glossary of Terms; References. 
520 |b Current World Health Organization and Centers for Disease Control and Prevention guidance for the disposal of liquid waste from patients undergoing treatment for Ebola virus disease at hospitals in the United States is to manage patient excreta as ordinary wastewater without pretreatment. The safety of non-disinfected disposal of Ebolavirus-contaminated liquid wastes and the efficacy of disinfection approaches are unknown, leading to concerns about the potential for Ebolavirus transmission to sewer workers. The goals of this research are twofold: 1) to assess a sewer worker's potential risk of developing Ebola virus disease from inhalation exposure when performing standard occupational activities in a sewer line serving a hospital receiving Ebola patients where there is no pretreatment of the waste prior to discharge, and 2) to conduct a review of inactivation of Ebola and other highly infectious agents by various disinfectants. Results from the quantitative microbial risk assessment suggest that the potential risk that sewer workers face when operating in a wastewater collection system downstream from a hospital receiving Ebola patients warrants further attention, and that current authoritative guidance for Ebolavirus liquid waste disposal may be insufficiently protective of sewer worker safety. Results from the inactivation review suggest that the effectiveness of various disinfectants on inactivation of highly infectious agents potentially found in wastewater collection systems, especially enveloped viruses, is variable and requires further evaluation for disposal and disinfection recommendations. 
504 |a Includes bibliographical references. 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a Ebola virus disease. 
650 0 |a Bacterial diseases. 
650 0 |a Hemorrhagic Fever, Ebola. 
650 2 |a Hemorrhagic Fever, Ebola 
650 6 |a Maladie à virus Ebola. 
650 6 |a Maladies bactériennes. 
650 7 |a Water supply & treatment.  |2 bicssc 
650 7 |a Bacterial diseases  |2 fast 
650 7 |a Ebola virus disease  |2 fast 
650 7 |a Environmental science, engineering & technology.  |2 thema 
650 7 |a Industrial applications of scientific research & technological innovation.  |2 thema 
650 7 |a Mining technology & engineering.  |2 thema 
650 7 |a Water supply & treatment.  |2 thema 
650 7 |a Environment and Ecology.  |2 ukslc 
700 1 |a Casson, Leonard. 
700 1 |a Haas, Charles N. 
758 |i has work:  |a Risks from Ebola Discharge from Hospitals to Sewer Workers (Text)  |1 https://id.oclc.org/worldcat/entity/E39PCYQjvYXprp7DjJt7gYbBXH  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 0 8 |i Print version:  |a Bibby, Kyle.  |t Risks from Ebola Discharge from Hospitals to Sewer Workers.  |d London : IWA Publishing, ©2016 
830 0 |a WERF Research Report Series. 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=4742392  |z Texto completo 
938 |a Askews and Holts Library Services  |b ASKH  |n AH31622682 
938 |a ProQuest Ebook Central  |b EBLB  |n EBL4742392 
994 |a 92  |b IZTAP